SFG
EW icon

Seamount Financial Group’s Edwards Lifesciences EW Stock Holding History

Seamount Financial Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300K Hold
3,312
– – 0.12% 113
2026
Q1 		$265K Hold
3,312
– – 0.12% 116
2025
Q4 		$282K Hold
3,312
– – 0.13% 116
2025
Q3 		$258K Hold
3,312
– – 0.12% 116
2025
Q2 		$259K Buy
+3,312
New +$247K 0.13% 112

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Seamount Financial Group's EW Position: Q2 2026 in Review

Seamount Financial Group held its Edwards Lifesciences (EW) position steady in Q2 2026 at 3,312 shares worth $300K. The position accounts for 0.12% of the portfolio, ranked #113.

Seamount Financial Group first reported a position in EW in Q2 2025 and has held it in 5 quarters since. 372 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Seamount Financial Group held 3,312 shares of Edwards Lifesciences worth $300K as of Q2 2026.
  • Seamount Financial Group left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.12% of Seamount Financial Group's portfolio in Q2 2026, its #113 holding.
  • Seamount Financial Group first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 5 quarters since.
  • 372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Seamount Financial Group's 13F filing for Q2 2026, filed 24 Jul 2026.